• VIDEO: 96-week data from EMERALD trial

    7 monthes ago - By Healio

    SAN FRANSCICO - In this video from IDWeek, Joseph Eron, MD, professor of medicine at the University of North Carolina School of Medicine and director of the UNC Center for AIDS Research Clinical Core, discusses 96-week data from EMERALD, a large randomized trial exploring the switch to a once-daily, single-tablet, darunavir-based regimen in HIV-infected adults who are virally suppressed and on treatment.
    According to Eron, only 3% of patients who switched to a regimen containing 800 mg of darunavir, 150 mg of cobicistat, 200 mg of emtricitabine and 10 mg of tenofovir alafenamide met the
    Read more ...